JP2012518648A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518648A5
JP2012518648A5 JP2011551272A JP2011551272A JP2012518648A5 JP 2012518648 A5 JP2012518648 A5 JP 2012518648A5 JP 2011551272 A JP2011551272 A JP 2011551272A JP 2011551272 A JP2011551272 A JP 2011551272A JP 2012518648 A5 JP2012518648 A5 JP 2012518648A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
virus
composition according
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551272A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518648A (ja
JP5951996B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/024914 external-priority patent/WO2010099064A1/en
Publication of JP2012518648A publication Critical patent/JP2012518648A/ja
Publication of JP2012518648A5 publication Critical patent/JP2012518648A5/ja
Application granted granted Critical
Publication of JP5951996B2 publication Critical patent/JP5951996B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551272A 2009-02-24 2010-02-22 イミノ糖及びアレナウイルス感染症を治療する方法 Expired - Fee Related JP5951996B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20239109P 2009-02-24 2009-02-24
US61/202,391 2009-02-24
US27225109P 2009-09-04 2009-09-04
US61/272,251 2009-09-04
PCT/US2010/024914 WO2010099064A1 (en) 2009-02-24 2010-02-22 Iminosugars and methods of treating arenaviral infections

Publications (3)

Publication Number Publication Date
JP2012518648A JP2012518648A (ja) 2012-08-16
JP2012518648A5 true JP2012518648A5 (enExample) 2013-03-21
JP5951996B2 JP5951996B2 (ja) 2016-07-13

Family

ID=42665853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551272A Expired - Fee Related JP5951996B2 (ja) 2009-02-24 2010-02-22 イミノ糖及びアレナウイルス感染症を治療する方法

Country Status (8)

Country Link
US (1) US20100222384A1 (enExample)
EP (1) EP2400843B1 (enExample)
JP (1) JP5951996B2 (enExample)
KR (2) KR20170117614A (enExample)
CN (1) CN102625660B (enExample)
CA (1) CA2753194A1 (enExample)
ES (1) ES2562635T3 (enExample)
WO (1) WO2010099064A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2398321B1 (en) 2009-02-23 2015-11-25 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
JP2015518896A (ja) 2012-06-06 2015-07-06 ユニザー ヴィロロジー,エルエルシー 新規イミノ糖およびそれらの用途
CN102775384B (zh) * 2012-07-27 2015-05-27 中国科学院化学研究所 小钩树碱i和j类似物及其制备方法与应用
US20160075651A1 (en) * 2013-05-02 2016-03-17 Unither Virology, Llc Glycolipid inhibition using iminosugars
EP3046558B1 (en) 2013-09-16 2019-08-14 Emergent Virology LLC Deoxynojirimycin derivatives and methods of their using
IT202000008917A1 (it) * 2020-04-24 2021-10-24 Biovalley Invest Partner S R L Composizioni antivirali
KR20250160378A (ko) 2024-05-06 2025-11-13 문제정 가구재용 서랍 조립시스템

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
WO1995022975A1 (en) * 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
JP2001525367A (ja) * 1997-12-11 2001-12-11 ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード 膜関連ウイルス複製の阻害
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
AU3595500A (en) * 1999-02-12 2000-08-29 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
CA2378776A1 (en) * 1999-07-26 2001-02-01 G.D. Searle & Co. Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
US6565487B1 (en) * 2000-07-17 2003-05-20 Hai Pin Kuo Exerciser having a forward and rearward adjusting seat
ES2619353T3 (es) * 2003-01-31 2017-06-26 Mount Sinai School Of Medicine Of New York University Terapia de combinación para tratar trastornos de deficiencia de proteínas
US7446098B2 (en) * 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
EP2058004A1 (en) * 2005-03-16 2009-05-13 University of Oxford Mannose immunogens for HIV-1
CN101355971A (zh) * 2005-05-17 2009-01-28 阿米库斯治疗学公司 使用1-去氧野尻霉素衍生物治疗庞皮病的方法
JP2008545657A (ja) * 2005-05-17 2008-12-18 アミカス セラピューティックス インコーポレイテッド 1−デオキシノジリマイシンおよび誘導体を用いるポンペ病の治療方法
KR20080031474A (ko) * 2005-07-27 2008-04-08 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 안구 질환의 치료를 위한 열충격의 사용
US20100004156A1 (en) * 2005-07-27 2010-01-07 Shalesh Kaushal Small Compounds That Correct Protein Misfolding and Uses Thereof
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
DE602007008870D1 (de) * 2006-04-24 2010-10-14 Amc Amsterdam Verbessertes verfahren zur behandlung von cystischer fibrose
ES2537572T3 (es) * 2006-05-24 2015-06-09 United Therapeutics Corporation Análogos de desoxinojirimicina y D-arabinitol y métodos de uso
EP2049126A2 (en) * 2006-08-02 2009-04-22 United Therapeutics Corporation Liposome treatment of viral infections
WO2008063727A2 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
US20090252785A1 (en) * 2008-03-26 2009-10-08 University Of Oxford Endoplasmic reticulum targeting liposomes
WO2010027996A1 (en) * 2008-09-02 2010-03-11 Institute For Hepatitis And Virus Research Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity

Similar Documents

Publication Publication Date Title
JP2012518648A5 (enExample)
JP2010526025A5 (enExample)
JP2012092103A5 (enExample)
JP2006522035A5 (enExample)
JP2012510502A5 (enExample)
JP2011037841A5 (enExample)
JP2010501534A5 (enExample)
JP2010504908A5 (enExample)
JP2009504763A5 (enExample)
JP2014515008A5 (enExample)
JP2005289914A5 (enExample)
JP2009535462A5 (enExample)
JP2010519270A5 (enExample)
JP2008501000A5 (enExample)
JP2008523126A5 (enExample)
JP2011504903A5 (enExample)
JP2009525302A5 (enExample)
JP2007246474A5 (enExample)
JP2009519903A5 (enExample)
JP2018135343A5 (enExample)
JP2015508092A5 (enExample)
JP2009543795A5 (enExample)
JP2014526533A5 (enExample)
JP2013503881A5 (enExample)
JP2012518649A5 (enExample)